Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 8/20 | 0.43 |
| ▸ | RAB9A | P51151 | 7/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.38 |
| ▸ | JAK2 | O60674 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.37 |
| ▸ | BCHE | P06276 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 4/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | GLA | P06280 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.37 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.36 |
| ▸ | KDR | P35968 | 1/20 | 0.36 |
| ▸ | FLT3 | P36888 | 1/20 | 0.36 |
| ▸ | MITF | O75030 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | JAK3 | P52333 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26458337 | 0.96 | NPC1 (0.43) | NPC1RAB9AKMT2ATLR9JAK2 | |
| SCHEMBL26458173 | 0.89 | MEN1 (0.41) | NPC1RAB9AKMT2ASMN1; SMN2MAPT | |
| SCHEMBL26458549 | 0.88 | MEN1 (0.40) | NPC1RAB9AKMT2ASMN1; SMN2MAPT | |
| SCHEMBL26458202 | 0.88 | MEN1 (0.40) | NPC1RAB9AKMT2ASMN1; SMN2MAPT | |
| SCHEMBL26458485 | 0.88 | NPC1 (0.44) | NPC1RAB9AKMT2ATLR9JAK2 | |
| SCHEMBL26458177 | 0.87 | MEN1 (0.47) | KMT2AMAPTALDH1A1GLALMNA | |
| SCHEMBL26458287 | 0.87 | MEN1 (0.47) | KMT2AMAPTALDH1A1GLALMNA | |
| SCHEMBL14278911 | 0.87 | NPC1 (0.45) | NPC1RAB9AKMT2AJAK2SMN1; SMN2 | |
| SCHEMBL22216700 | 0.87 | MEN1 (0.39) | NPC1RAB9AKMT2ASMN1; SMN2MAPT | |
| SCHEMBL22216678 | 0.87 | MEN1 (0.39) | NPC1RAB9AKMT2ASMN1; SMN2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11641778-B2 | Compound and organic light emitting device comprising same | LG CHEM, LTD. (KR) | 2023-05-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11641778-B2 | Compound and organic light emitting device comprising same | CRY1, CYP1A1, CRY2 | NPC1 1521/4885RAB9A 2344/4885KMT2A 1182/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.